UK markets closed

Amphastar Pharmaceuticals, Inc. (29A.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
39.04-0.66 (-1.66%)
As of 09:24AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
676,209
644,395
498,987
437,768
349,846
Cost of revenue
308,828
293,274
250,127
238,029
206,506
Gross profit
367,381
351,121
248,860
199,739
143,340
Operating expenses
Research development
70,969
73,741
74,771
60,932
67,229
Selling general and administrative
84,848
80,393
66,592
68,920
65,157
Total operating expenses
155,817
154,134
141,363
129,852
132,386
Operating income or loss
211,564
196,987
107,497
69,887
10,954
Interest expense
-
27,158
1,846
885
374
Total other income/expenses net
-3,673
-3,929
9,068
14,536
-6,585
Income before tax
185,666
171,359
116,040
84,139
4,637
Income tax expense
29,207
31,833
23,477
20,630
3,540
Income from continuing operations
154,690
137,545
91,386
63,301
1,097
Net income
154,690
137,545
91,386
62,116
1,403
Net income available to common shareholders
154,690
137,545
91,386
62,116
1,403
Basic EPS
2.80
2.85
1.88
1.30
0.03
Diluted EPS
2.56
2.60
1.74
1.25
0.03
Basic average shares
48,351
48,265
48,551
47,777
47,038
Diluted average shares
52,676
53,001
52,427
49,784
49,124